Viewing nowClodorel 75 mg (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Joah Pharmaceutical Co., Ltd.

MFDS item code 201604022 · Approved 2016.06.28 · Insurance code 644603490
Improvement of atherosclerosis symptoms, treatment of acute coronary syndrome, and prevention of thromboembolism in atrial fibrillation
This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. It also alleviates atherosclerotic symptoms due to cardiovascular issues in patients with acute coronary syndrome who have undergone or will undergo coronary interventional procedures or coronary artery bypass surgery. This medication helps reduce the risk of stroke and thromboembolism in patients with atrial fibrillation who have one or more vascular risk factors and for whom vitamin K antagonists are not suitable and the risk of bleeding is low. Therefore, it is effectively used for the prevention of cardiovascular diseases and strokes.
○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg of this medicine once daily, followed by a maintenance dose of 75 mg once daily orally. Aspirin 75 ~ 325 mg should be coadministered with this medicine once daily. 3. In patients with atrial fibrillation, administer this medicine 75 mg orally once daily. Aspirin 75 ~ 100 mg should be coadministered with this medicine once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease and bleeding diathesis is limited. This medicine may be administered with or without food.
This medication helps prevent platelets from aggregating, allowing blood to flow properly. However, individuals with a genetically reduced function of the specific enzyme CYP2C19 may find that this medication does not work effectively, and in such cases, alternative treatment methods should be considered. Additionally, using this medication with drugs that activate CYP2C19 may lead to an accumulation of the medication in the body, increasing the risk of bleeding, so they should not be used together. Patients with an allergy to this medication or experiencing bleeding, patients with severe liver dysfunction, breastfeeding women, and those unable to break down lactose due to specific genetic issues should not take this medication. Patients at high risk of bleeding, those with liver or kidney dysfunction, individuals who have recently experienced a stroke, patients with ongoing hypertension, elderly patients, and those with low body weight should use this medication with caution. Especially, using this medication along with other drugs that increase bleeding risk may further increase the risk of bleeding. Patients scheduled for surgery should discontinue this medication 5 to 7 days before the procedure and resume it once hemostasis is achieved post-surgery. While taking this medication, bleeding may take longer to stop, so if bleeding is suspected, the doctor should be notified immediately. Patients on this medication should inform healthcare providers when undergoing surgery or starting new medications. Rarely, severe blood disorders with a rapid decline in platelets may occur, so if symptoms of fever or infection develop, tests should be conducted immediately. This medication may cause side effects such as indigestion, diarrhea, headache, dizziness, rash, etc., and bleeding symptoms should be monitored carefully. During pregnancy, this medication is not known to pose significant risks to the fetus, but due to the risk of bleeding during delivery, it is recommended to stop taking this medication prior to labor. Breastfeeding women should discuss with healthcare providers whether to continue breastfeeding, as this medication can be found in breast milk. The safety and efficacy of this medication in children have not been adequately established. Elderly patients may have increased bleeding risk due to diminished kidney or liver function, requiring careful monitoring during treatment. In cases of overdose, the risk of bleeding may increase, and while there is no specific antidote, treatment such as platelet transfusion may be necessary in severe cases of bleeding. This medication should be stored out of the reach of children and should not be transferred to other containers.
Bleeding, gastrointestinal bleeding, bleeding requiring hospitalization, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, major bleeding, life-threatening bleeding, fatal bleeding, hemorrhagic stroke, transfusion-required bleeding, skin and skin appendages adverse reactions, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, gastrointestinal symptoms, abdominal pain, dyspepsia, diarrhea, nausea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, depression, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, exercise intolerance, tremor, voice disorder, abnormal gait, hyperkinesis, ataxia, sensory disturbances, insomnia, depression, forgetfulness, anxiety, mania, thought disturbances, abnormal behavior, arthralgia, myalgia, back pain, weight loss, weight gain, facial flushing, weakness, rigidity, facial edema, syncope, purpura syndrome, melena, thrombocytopenia, anemia, pneumonia, sinusitis, visual disturbances, visual field defects, dry eye syndrome, temporary blindness, congestion, tinnitus, taste disturbances, urination disorders, polyuria, hypoglycemia, hyperuricemia, elevated liver enzymes, ALT elevation, liver function abnormalities, leg edema, arrhythmia, bradycardia, palpitations, contact dermatitis, gynecomastia, elevated prostate-specific antigen, loss of appetite, hematemesis, cholecystitis, spinal hematoma, allergic symptoms, ischemic necrosis, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal ulcer bleeding, distention, hyperbilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hematuria, hemoptysis, pulmonary hemorrhage, serum sickness, anaphylactoid reaction, confusion, hallucination, loss of taste, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, stomatitis, hepatitis, acute liver failure, herpes zoster, erythema multiforme, maculopapular rash, urticaria, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, eosinophilia, drug rash, eczema, lichen planus, arthritis, glomerulopathy, gynecomastia, fever, abnormal liver function tests, elevated blood creatinine, exercise intolerance, tremor, voice disorder, abnormal gait, hyperkinesis, ataxia, hiccup, dysphagia, tongue disease, abnormal behavior, rigidity, visual field defects, dry eye syndrome, temporary blindness, congestion, urination disorders, uremia, hypoglycemia, bradycardia, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius to maintain the medication's effectiveness.
Pink, round, film-coated tablet
Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Joah Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.